NEXEL Co., Ltd.
PrivateLast Round
Private Equity
Apr 28, 2023
Est. Valuation
$78.47M
Total Funding Raised
$41.38M
Company Overview
NEXEL Co., Ltd. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Private Equity round in April 2023.
NEXEL Co., Ltd. is a biotechnology company that provides drug discovery pipelines and develops high-quality induced pluripotent stem cell (iPSC)-derived cell products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEXEL Co., Ltd. Comparables
Compare NEXEL Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celogics | 88% | |
| Axol Bioscience | 86% | |
| ReproCELL Incorporated | 84% |
For institutional investors. Book with your work email.
NEXEL Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Apr 28, 2023 | ||||
| Series B Extension | Apr 16, 2021 | ||||
| Series B | Aug 1, 2019 | ||||
| Series A | Dec 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NEXEL Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series B Extension |
| SL Investment | Series B Extension |
| UTC Investment | Series B Extension, Series B, Private Equity |
| Friend Investment Partners | Series B Extension |
| Comes Investment | Series B Extension, Series B |
| BSK Investment | Series B Extension |
| Medici Investment | Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 48% MoM.
- Nov 7, 2025
Monthly visitors grew 100% MoM, reaching 5.7K.
For institutional investors. Book with your work email.
NEXEL Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NEXEL Co., Ltd.'s valuation, stock price, and market status.
Is NEXEL Co., Ltd. a public or private company?
NEXEL Co., Ltd. is a private company.
What is the current stock price of NEXEL Co., Ltd.?
NEXEL Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks NEXEL Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NEXEL Co., Ltd. worth (valuation)?
NEXEL Co., Ltd.'s valuation is estimated at $78.5M based on funding round data.
Can I buy NEXEL Co., Ltd. stock?
NEXEL Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NEXEL Co., Ltd.'s last funding round?
NEXEL Co., Ltd.'s most recent funding round was Private Equity on April 28, 2023.
Who are the main investors in NEXEL Co., Ltd.?
Key investors in NEXEL Co., Ltd. include Korea Development Bank.
Will NEXEL Co., Ltd. IPO soon?
No public IPO plans have been announced for NEXEL Co., Ltd..
How can I track NEXEL Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in NEXEL Co., Ltd.'s shares on secondary markets.